![Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence | Science Immunology Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence | Science Immunology](https://www.science.org/cms/10.1126/sciimmunol.abf8891/asset/e796a5b7-33f6-477d-8b05-3c9776f26166/assets/graphic/abf8891-f1.jpeg)
Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence | Science Immunology
![Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals | bioRxiv Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2021/06/17/2021.06.17.448459/F3.large.jpg)
Memory B cells control SARS-CoV-2 variants upon mRNA vaccination of naive and COVID-19 recovered individuals | bioRxiv
![Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology](https://www.science.org/cms/asset/370065e6-9aa7-487e-bb18-ad49de12ac0d/abe0240-f1.gif)
Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome | Science Immunology
![Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor. - ppt download Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor. - ppt download](http://slideplayer.com/90/14753237/big_thumb.jpg)
Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease by Joshua J. Field, Elaine Majerus, Victor. - ppt download
Rituximab-resistant splenic memory B cells and newly engaged naive B cells fuel relapses in patients with immune thrombocytopeni
![PDF) The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease PDF) The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease](https://i1.rgstatic.net/publication/269726294_The_use_of_rituximab_to_prevent_severe_delayed_haemolytic_transfusion_reaction_in_immunized_patients_with_sickle_cell_disease/links/5b5054780f7e9b240feca2c6/largepreview.png)
PDF) The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease
![Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine](https://www.science.org/cms/asset/9b180ae7-1ad6-461b-987e-c9f0bc1ae330/abd5487-f1.gif)
Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients | Science Translational Medicine
![Covid-19: study on the effectiveness of immune memory after mRNA vaccination to recognize variants of SARS-CoV-2 | Institut Pasteur Covid-19: study on the effectiveness of immune memory after mRNA vaccination to recognize variants of SARS-CoV-2 | Institut Pasteur](https://www.pasteur.fr/sites/default/files/styles/media-wide/public/rubrique_espace_presse/documents_de_presse/communiques_de_presse/cp_2021/explications.png?itok=mHs0dPFI&language=fr)